Source:http://linkedlifedata.com/resource/pubmed/id/17596500
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-6-28
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1935-5548
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e77; author reply e78
|
pubmed:meshHeading |
pubmed-meshheading:17596500-Diabetes Mellitus, Type 2,
pubmed-meshheading:17596500-Female,
pubmed-meshheading:17596500-Humans,
pubmed-meshheading:17596500-Hyperglycemia,
pubmed-meshheading:17596500-Hyperinsulinism,
pubmed-meshheading:17596500-Hypoglycemic Agents,
pubmed-meshheading:17596500-Male,
pubmed-meshheading:17596500-Neoplasms,
pubmed-meshheading:17596500-Risk
|
pubmed:year |
2007
|
pubmed:articleTitle |
Prospective study of hyperglycemia and cancer risk: response to Stattin et al.
|
pubmed:publicationType |
Letter,
Comment
|